Peker, HakanAtasayan, KemalPeker, Berna HaliloğluKilicci, Çetin2024-07-122024-07-1220210353-95041332-816610.3325/cmj.2021.62.4722-s2.0-85121053856https://doi.org/10.3325/cmj.2021.62.472https://hdl.handle.net/20.500.12415/7164Aim To investigate the efficacy of intraoperative superior hypogastric plexus (SHP) block for postoperative pain relief in patients undergoing a cesarean section. Methods One hundred and fifteen pregnant women scheduled for an elective cesarean under general anesthesia were randomly divided into an SHP block (n = 65) and a control group (n = 50). SHP block was administered with bupivacaine injection. The controls received saline injection in the SHP area. Postoperative pain was assessed by the 10-cm visual analog scale (VAS). The presence of side effects and complications, including opioid or non -steroidal anti-inflammatory drugs (NSAID) requirement, gastrointestinal function, nausea, and vomiting were evaluated. Results The SHP block group had significantly lower VAS scores 2, 6, 24, and 48 hours postoperatively (P < 0.001) and required a significantly lower rescue dose of NSAID or opioids (P = 0.003, P < 0.05, respectively). Conclusions SHP block may be an effective and safe pain relief treatment after a cesarean section.eninfo:eu-repo/semantics/openAccessArticle479534730887Q347262WOS:000717328800007Q3